Technology News Portal
The patent protection period in India for semaglutide, the active ingredient in Ozempic developed by the Denmark-based healthcare company Novo Nordisk, has expired. Following this development, at least four major India-based pharmaceutical manufacturers have taken action to launch generic versions of the drug, which is highly sought after globally for the treatment of obesity and […]
Weight loss drugs are medical products designed to support weight reduction by suppressing appetite, increasing the feeling of fullness, or influencing metabolic processes. In recent years, especially with the rise of new-generation injectable treatments, interest in this field has grown rapidly. The observation that some drugs originally developed for obesity treatment led to significant weight […]